EUVIMEDEUVIMED entdecken
Crossref

Surgical Ablation for Atrial Fibrillation During Minimally Invasive Mitral Valve Surgery: Risk Dependencies and Long-Term Survival

Mariusz Kowalewski iD, Giuseppe Maria Raffa, Jakub Batko iD, Michał Święczkowski, Emil Julian Dąbrowski, Karol Gostomczyk iD, Łukasz Kuźma, Wojciech Wańha, Radosław Litwinowicz, Tomasz Urbanowicz, Fabrizio D'Ascenzo, Marek Jasiński und 12 weitere

Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery · 2026-07 · 21 (4) · 368-376

DOI: 10.1177/15569845261472462 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, online erschienen am 07.09.2026. Verfasst von Mariusz Kowalewski und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery and Transplantology, National Medical Institute of the Ministry of Interior and Administration, Warsaw, Poland. Hauptthemen laut MEDLINE: Atrial Fibrillation, Minimally Invasive Surgical Procedures, Mitral Valve, Heart Valve Diseases. Die Arbeit nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Atrial fibrillation (AF) is a common finding among patients with mitral valve disease, with a growing body of evidence showing survival benefits associated with surgical ablation (SA). However, a lack of data persists regarding the safety and survival after SA concomitant to minimally invasive mitral valve surgery (MIMVS).

Methods

We retrospectively collected data from the Polish National Registry of Cardiac Surgery Procedures (Krajowy Rejestr Operacji Kardiochirurgicznych), searching for all adult patients with AF who underwent MIMVS between 2006 and 2021. Initially, 1,545 patients were identified; SA was performed on 512 patients (33.2%). Propensity score matching comparing MIMVS + SA versus MIMVS alone was performed.

Results

Matching resulted in 365 pairs with similar baseline characteristics (median age = 65 years, interquartile range [IQR]: 58 to 70 years; median EuroSCORE II = 2.2%, IQR: 1.4 to 3.4). We observed no differences in 24 h mortality for MIMVS + SA versus MIMVS alone (0.3% vs 0.0%, P = 0.99). Although there was no difference in in-hospital complications, neurologic complications were reported less frequently in the SA group (2.7% vs 8.2%, P = 0.002). Unadjusted survival analysis favored MIMVS+SA (hazard ratio [HR] = 0.52, 95% confidence interval [CI]: 0.40 to 0.69, P < 0.001). However, after adjustment for baseline risk factors, the effect was no longer significant (HR = 0.85, 95% CI: 0.56 to 1.32, P = 0.48). When stratified on baseline CHA 2 DS 2 -VASc score, a gradient of benefit was seen, with patients at higher thromboembolic risk gaining the most benefits from concomitant SA.

Conclusions

Patients with a higher thromboembolic risk gain the most benefits from concomitant SA. SA was associated with fewer neurologic complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationMinimally Invasive Surgical ProceduresMitral ValveHeart Valve DiseasesCatheter AblationHumansFemaleMiddle AgedRetrospective StudiesMaleAgedPolandRegistriesRisk FactorsTreatment OutcomePostoperative ComplicationsPropensity Score

Stichwörter der Autor:innen

minimally invasive surgerymitral valvemitral valve surgerysurgical ablation

Autor:innen und Institutionen

  • Department of Cardiac Surgery and Transplantology, National Medical Institute of the Ministry of Interior and Administration, Warsaw, Poland.
  • Cardio-Thoracic Surgery Department, Heart and Vascular Centre, Maastricht University Medical Centre (MUMC), Cardiovascular Research Institute Maastricht (CARIM), The Netherlands.
  • Thoracic Research Centre, Collegium Medicum Nicolaus Copernicus University, Innovative Medical Forum, Bydgoszcz, Poland.
  • Cardiac Surgery Unit, Department of Precision Medicine in Medical Surgical and Critical Area (Me.Pre.C.C.), University of Palermo, Italy.
  • Department of Cardiovascular Surgery and Transplantology, Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland.
  • Department of Invasive Cardiology, Medical University of Bialystok, Poland.

ORCID-Profile: Mariusz Kowalewski, Jakub Batko, Karol Gostomczyk, Marek Deja, Piotr Suwalski

Zitieren

APA

Kowalewski, M., Raffa, G. M., Batko, J., Święczkowski, M., Dąbrowski, E. J., Gostomczyk, K., Kuźma, Ł., Wańha, W., Litwinowicz, R., Urbanowicz, T., D'Ascenzo, F., Jasiński, M., Widenka, K., Deja, M., Bartuś, K., Hirnle, T., Wojakowski, W., Pilato, M., Musumeci, F., …, & Suwalski, P. (2026). Surgical Ablation for Atrial Fibrillation During Minimally Invasive Mitral Valve Surgery: Risk Dependencies and Long-Term Survival. Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, 21(4), 368-376. https://doi.org/10.1177/15569845261472462

Vancouver

Kowalewski M, Raffa GM, Batko J, Święczkowski M, Dąbrowski EJ, Gostomczyk K, et al. Surgical Ablation for Atrial Fibrillation During Minimally Invasive Mitral Valve Surgery: Risk Dependencies and Long-Term Survival. Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery. 2026;21(4):368-376. doi:10.1177/15569845261472462

BibTeX
@article{Kowalewski2026,
  author = {Kowalewski, Mariusz and Raffa, Giuseppe Maria and Batko, Jakub and Święczkowski, Michał and Dąbrowski, Emil Julian and Gostomczyk, Karol and Kuźma, Łukasz and Wańha, Wojciech and Litwinowicz, Radosław and Urbanowicz, Tomasz and D'Ascenzo, Fabrizio and Jasiński, Marek and Widenka, Kazimierz and Deja, Marek and Bartuś, Krzysztof and Hirnle, Tomasz and Wojakowski, Wojciech and Pilato, Michele and Musumeci, Francesco and Lorusso, Roberto and Pisano, Calogera and Tobota, Zdzisław and Maruszewski, Bohdan J and Suwalski, Piotr},
  title = {Surgical Ablation for Atrial Fibrillation During Minimally Invasive Mitral Valve Surgery: Risk Dependencies and Long-Term Survival},
  journal = {Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery},
  year = {2026},
  volume = {21},
  number = {4},
  pages = {368--376},
  doi = {10.1177/15569845261472462}
}
Kostenlos starten →